Home » Topics » BioWorld Science

BioWorld Science
RSS

New neonatal murine model of Listeria monocytogenes meningitis developed

July 19, 2021

Scioto opens phase I study of SB-121 in participants with autistic disorder

July 19, 2021

BIX-119 leads to improved clinical benefit through blocking both IL-17 and IL-22

July 19, 2021

ABBV-CLS-7262 studied in phase I for ALS

July 19, 2021

Phase I trial investigates SHJ-002 for myopia in pediatric subjects

July 19, 2021

FDA clears IND for phase I trial of SYSA-1801 in advanced pancreatic cancer

July 19, 2021

UCB discloses new FCER1A mutant inhibitors

July 19, 2021

FDA accepts IND application for phase IIa study of Quilience as treatment of narcolepsy

July 19, 2021

Wigen Biomedicine Technology presents KRAS mutant inhibitors

July 19, 2021

TYK Medicines divulges new Ret inhibitors

July 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...